Early stopping of trials

[Diagnostic mode and tumor staging of breast cancers in the setting of opportunistic screenings].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2006

[Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].

RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin·2004

'Safe prescribing' ('Sicherer verordnen')-information on drug safety for German physicians.

Pharmacoepidemiology and drug safety·2004

Database of adverse events occurring in clinical studies--useful and necessary?

Pharmacoepidemiology and drug safety·2004

Understanding medication-related needs of low-literacy patients.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·1996

Investigation into the combined effects of ethanol and cadmium on rat liver and kidneys.

Archives of toxicology·1990

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Chemical Bond-Orchestrated Energy Depletion to Augment Lung Cancer Chemo-Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

PROTAC-Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Buddy Wire-Augmented Intravascular Lithotripsy in Refractory Calcified Coronary Lesions: A Five-Case Series.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Poly(2-oxazoline) micelles for co-delivery of paclitaxel and metronidazole benzoate for dual chemotherapeutic and antibacterial targeting in the tumor microenvironment.

Biomedical microdevices·2026

Conservative and surgical treatment of wrist osteoarthritis: a systematic review.

Archives of orthopaedic and trauma surgery·2026

The pre-treatment tumor microenvironment immune status determines Bacillus Calmette-Guerin immunotherapy response in early-stage bladder cancer.

Cancer immunology research·2026

Related Experiment Videos

Early stopping of trials

Related Concept Videos

[Diagnostic mode and tumor staging of breast cancers in the setting of opportunistic screenings].

[Ultrasound follow-up of palpable solid, probably benign breast lesions (BI-RADS category III)].

'Safe prescribing' ('Sicherer verordnen')-information on drug safety for German physicians.

Database of adverse events occurring in clinical studies--useful and necessary?

Understanding medication-related needs of low-literacy patients.

Investigation into the combined effects of ethanol and cadmium on rat liver and kidneys.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Chemical Bond-Orchestrated Energy Depletion to Augment Lung Cancer Chemo-Immunotherapy.

PROTAC-Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy.

Buddy Wire-Augmented Intravascular Lithotripsy in Refractory Calcified Coronary Lesions: A Five-Case Series.

Poly(2-oxazoline) micelles for co-delivery of paclitaxel and metronidazole benzoate for dual chemotherapeutic and antibacterial targeting in the tumor microenvironment.

Conservative and surgical treatment of wrist osteoarthritis: a systematic review.

The pre-treatment tumor microenvironment immune status determines Bacillus Calmette-Guerin immunotherapy response in early-stage bladder cancer.

Related Experiment Videos

Early stopping of trials

Related Concept Videos

Related Articles